Summary
Quest PharmaTech Inc. (Quest) is a biotechnology company that develops and commercializes oncology product candidates. The company’s products include anti CA125 MAb oregovomab, anti MUC1 MAb AR20.5 and SL052. Its anti CA125 MAb Oregovomab is an immunotherapeutic product for the treatment of ovarian cancer. Quest SL052 is an injectable formulation that is in phase I clinical trials used for the treatment of prostate cancer. The company develops product candidates for the treatment of cancer by combining immunotherapeutic antibodies with chemotherapy, photodynamic therapy and immunoadjuvants. Quest is headquartered in Edmonton, Alberta, Canada.
Quest PharmaTech Inc. (QPT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Quest PharmaTech Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Quest PharmaTech Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Quest PharmaTech Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Quest PharmaTech Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Quest PharmaTech Inc., Medical Devices Deals, 2010 to YTD 2016 9
Quest PharmaTech Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Quest PharmaTech Inc., Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
OncoQuest Acquires Immuno-Photodynamic Therapy Assets from Quest Pharma for USD2 Million 11
Quest PharmaTech To Acquire AllergoOncology Technology Of Advanced Immune Therapeutics 12
Partnerships 13
OncoQuest and Shenzhen Hepalink Pharma Forms Joint Venture 13
Quest PharmaTech Enters Into Co-Development Agreement With AD Biotech 14
Licensing Agreements 15
Quest PharmaTech Enters into Licensing Agreement with Bioceltran 15
Quest PharmaTech Enters Into Licensing Agreement With Oncovir For Hiltonol 16
Quest PharmaTech Enters Into Licensing Agreement With Stanford University For Anti-MUC1 IgE Technology 18
Quest PharmaTech Enters Into Licensing Agreement With University Of California At Los Angeles For Cancer Treatment 19
Equity Offering 20
OncoQuest Raises USD13 Million in Private Placement of Preference Shares 20
Quest PharmaTech Raises USD1.5 Million in Private Placement of Shares 21
Quest PharmaTech Raises USD0.8 Million in Private Placement of Units 23
Quest PharmaTech Completes Private Placement Of Units For US$1 Million 24
Quest PharmaTech Announces Private Placement Of Shares For US$7.7 Million 25
Quest PharmaTech Completes Private Placement Of Shares For US$0.5 Million 26
Quest PharmaTech Completes Non-Brokered Private Placement Of Units For US$0.6 Million 27
Asset Transactions 28
OncoQuest Acquires Immuno-Photodynamic Therapy Assets from Quest Pharma for USD2 Million 28
Quest PharmaTech Inc. - Key Competitors 29
Key Employees 30
Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List of Tables
Quest PharmaTech Inc., Pharmaceuticals & Healthcare, Key Facts, 2015 1
Quest PharmaTech Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Quest PharmaTech Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Quest PharmaTech Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Quest PharmaTech Inc., Deals By Therapy Area, 2010 to YTD 2016 8
Quest PharmaTech Inc., Medical Devices Deals, 2010 to YTD 2016 9
Quest PharmaTech Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
OncoQuest Acquires Immuno-Photodynamic Therapy Assets from Quest Pharma for USD2 Million 11
Quest PharmaTech To Acquire AllergoOncology Technology Of Advanced Immune Therapeutics 12
OncoQuest and Shenzhen Hepalink Pharma Forms Joint Venture 13
Quest PharmaTech Enters Into Co-Development Agreement With AD Biotech 14
Quest PharmaTech Enters into Licensing Agreement with Bioceltran 15
Quest PharmaTech Enters Into Licensing Agreement With Oncovir For Hiltonol 16
Quest PharmaTech Enters Into Licensing Agreement With Stanford University For Anti-MUC1 IgE Technology 18
Quest PharmaTech Enters Into Licensing Agreement With University Of California At Los Angeles For Cancer Treatment 19
OncoQuest Raises USD13 Million in Private Placement of Preference Shares 20
Quest PharmaTech Raises USD1.5 Million in Private Placement of Shares 21
Quest PharmaTech Raises USD0.8 Million in Private Placement of Units 23
Quest PharmaTech Completes Private Placement Of Units For US$1 Million 24
Quest PharmaTech Announces Private Placement Of Shares For US$7.7 Million 25
Quest PharmaTech Completes Private Placement Of Shares For US$0.5 Million 26
Quest PharmaTech Completes Non-Brokered Private Placement Of Units For US$0.6 Million 27
OncoQuest Acquires Immuno-Photodynamic Therapy Assets from Quest Pharma for USD2 Million 28
Quest PharmaTech Inc., Key Competitors 29
Quest PharmaTech Inc., Key Employees 30
Quest PharmaTech Inc., Subsidiaries 31
List of Figures
Quest PharmaTech Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Quest PharmaTech Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Quest PharmaTech Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Quest PharmaTech Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Quest PharmaTech Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Quest PharmaTech Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Quest PharmaTech Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Quest PharmaTech Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Quest PharmaTech Inc., Medical Devices Deals, 2010 to YTD 2016 9
